Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Wilson disease is a single gene disorder - comprehensive analysis of patients with prior negative genetic testing.

JHEP reports : innovation in hepatology·2026

Same author

Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease.

JHEP reports : innovation in hepatology·2026

Same author

Clinical and Genetic Profile of Pediatric and Adult Wilson's Disease in India.

Gastro hep advances·2025

Same author

Diagnosing Wilson Disease in Acute Liver Failure: Comparison of Existing and Experimental Biomarkers.

The American journal of gastroenterology·2025

Same author

Erratum: Effects of trientine and penicillamine on intestinal copper uptake: A mechanistic 64 Cu PET/CT study in healthy humans.

Hepatology (Baltimore, Md.)·2025

Same author

Changes in the FXR-cistrome and alterations in bile acid physiology in Wilson disease.

Hepatology communications·2025

Search research articles

Related Experiment Video

Updated: Jan 10, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Inherited metabolic disease.

Michael L Schilsky¹

¹Department of Medicine, Division of Liver Diseases, and Recanati/Miller Transplantation Institute, Mount Sinai School of Medicine, New York, New York 10029, USA. michael.schilsky@mssm.edu

Current Opinion in Gastroenterology

|October 13, 2006

Summary

This review explores liver disease genetics and metabolic pathways, advancing understanding and treatment. It focuses on Wilson disease, hemochromatosis, and alpha(1)-antitrypsin deficiency.

More Related Videos

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Related Experiment Videos

Last Updated: Jan 10, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Area of Science:

Hepatology and Genetic Medicine

Background:

Understanding liver disease pathogenesis is crucial for advancing treatment options.
Elucidating metabolic pathways and genetic underpinnings enhances disease comprehension.

Purpose of the Study:

To provide a selective review of liver disease pathogenesis and management.
To focus on three specific genetic liver disorders: Wilson disease, hereditary iron overload, and alpha(1)-antitrypsin disease.

Main Methods:

Selective review of current literature on liver disease.
Identification of novel proteins and key transport pathways.
Analysis of phenotypic expression and treatment strategies.

Main Results:

Advances in understanding disease pathogenesis through metabolic and genetic insights.
Comprehensive overview of novel protein identification and transport pathway significance.
Detailed examination of phenotypic variations and acute liver failure management.

Conclusions:

Elucidation of metabolic pathways and genetic basis significantly advances liver disease understanding.
Focus on specific genetic disorders provides in-depth insights into pathogenesis and management.
The review highlights progress in identifying therapeutic targets and improving patient outcomes.